Gsα-dependent signaling is required for postnatal establishment of a functional β-cell mass
Berta Serra-Navarro(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Rosa Gasa(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Eduardo Fernández‐Rebollo(Hospital de Cruces), Rebeca Fernandez‐Ruiz(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), J. P. Mathieu, Yaiza Esteban(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Ainhoa García(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Joan Mir-Coll(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Max Hahn(Umeå University), Marta Pradas-Juni(University of Southern Denmark), Stéphane Dalle(Hospices Civils de Lyon), Ulf Ahlgren(Umeå University), Lee S. Weinstein(National Institute of Diabetes and Digestive and Kidney Diseases), Ramón Gomis(Universitat de Barcelona), Josép Vidal(Instituto de Salud Carlos III)
Cited by 11
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
Optical Projection Tomography as a Tool for 3D Microscopy and Gene Expression Studies
|Science|2002|1.2k